Synthesis and structure-activity relationship of non-peptidic antagonists of neuropilin-1 receptor

被引：28

作者：

Liu, Wang-Qing ^{[1
]}

Megale, A. Valentino ^{[2
]}

Borriello, Lucia ^{[1
,2
,3
]}

Leforban, Bertrand ^{[1
,3
]}

Montes, Matthieu ^{[4
]}

Goldwaser, Elodie ^{[2
,3
]}

Gresh, Nohad ^{[1
,2
]}

Piquemal, Jean-Philip ^{[5
]}

Hadj-Slimane, Reda ^{[3
]}

Hermine, Olivier ^{[6
,7
,8
]}

Garbay, Christiane ^{[1
,2
]}

Raynaud, Francoise ^{[1
,2
]}

Lepelletier, Yves ^{[6
,7
,8
]}

Demange, Luc ^{[1
,2
,9
]}

机构：

[1] Univ Paris 05, Lab Mol & Cellular Pharmacochem, INSERM U648, Sorbonne Paris Cite,UFR Biomed St Peres, F-75270 Paris 06, France

[2] Univ Paris 05, Lab Chim & Biochim Pharmacol & Toxicol, UMR CNRS 8601, Sorbonne Paris Cite,UFR Biomed St Peres, F-75270 Paris 06, France

[3] Tragex Pharma, F-92100 Boulogne, France

[4] Conservatoire Natl Arts & Metiers, Chaire Bioinformat, Lab Genom Bioinformat & Applicat, EA 4627, F-75003 Paris, France

[5] Univ Paris 06, Sorbonne Univ, Chim Theor Lab, F-75252 Paris, France

[6] INSERM UMR 1163, Lab Cellular & Mol Basis Normal Hematopoiesis & H, F-75015 Paris, France

[7] Paris Descartes Univ, Imagine Inst, Sorbonne Paris Cite, F-75015 Paris, France

[8] CNRS ERL 8254, F-75015 Paris, France

[9] Univ Nice Sophia Antipolis, CNRS, UMR 7272, Inst Chim Nice, F-06108 Nice 1, France

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2014年 / 24卷 / 17期

关键词：

Angiogenesis; Neuropilin; Protein-protein interaction; Docking to receptor; Heterocycles; ENDOTHELIAL GROWTH-FACTOR; END-RULE PEPTIDES; EFFICIENT SYNTHESIS; SEMAPHORIN-III; BREAST-CANCER; BINDING; ANGIOGENESIS; VEGF; OSTEOARTHRITIS; CORECEPTORS;

D O I：

10.1016/j.bmcl.2014.07.028

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Neuropilins (NRPs) are VEGF-A(165) co-receptors over-expressed in tumor cells, and considered as targets in angiogenic-related pathologies. We previously identified compound 1, the first non-peptidic antagonist of the VEGF-A(165)/NRP binding, which exhibits in vivo anti-angiogenic and anti-tumor activities. We report here the synthesis and biological evaluations of new antagonists structurally-related to compound 1. Among these molecules, 4a, 4c and 4d show cytotoxic effects on HUVEC and MDA-MB-31 cells, and antagonize VEGF-A(165)/NRP-1 binding. This study confirmed our key structure-activity relationships hypothesis and paved the way to compound 1 'hit to lead' optimization. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：4254 / 4259

页数：6

共 50 条

[41] The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists
Lunniss, Gillian E.
Barnes, Ashley A.
Barton, Nick
Biagetti, Matteo
Bianchi, Federica
Blowers, Stephen M.
Caberlotto, Laura L.
Emmons, Amanda
Holmes, Ian P.
Montanari, Dino
Norris, Roz
Puckey, Gemma V.
Walters, Dewi J.
Watson, Steve P.
Willis, John
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7341 - 7344
[42] ON THE STRUCTURE-ACTIVITY RELATIONSHIP IN NARCOTIC ANALGESICS AND THEIR ANTAGONISTS
KRYLOV, SS
KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1992, 26 (7-8): : 122 - 125
[43] Structure-activity relationship of potential antagonists of brevetoxins
Michelliza, S
Bourdelais, AJ
Jacocks, HM
Abraham, WM
Baden, DG
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U3418 - U3419
[44] Structure-activity relationship analysis of a series of nonsteroidal analogues as androgen receptor antagonists
Yuan, Miao
Cheng, Ping
Zhang, Shuping
NEW JOURNAL OF CHEMISTRY, 2021, 45 (03) : 1176 - 1186
[45] SAR analysis of novel non-peptidic NPBWR1 (GPR7) antagonists
Guerrero, Miguel
Urbano, Mariangela
Schaeffer, Marie-Therese
Brown, Steven
Rosen, Hugh
Roberts, Edward
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 614 - 619
[46] Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: Potent and selective adenosine A(1) receptor antagonists
Poulsen, SA
Quinn, RJ
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (21) : 4156 - 4161
[47] Non-peptidic αvβ3 antagonists containing indol-1-yl propionic acids
Leonard, K
Pan, WX
Anaclerio, B
Gushue, JM
Guo, ZH
DesJarlais, RL
Chaikin, MA
Lattanze, J
Crysler, C
Manthey, CL
Tomczuk, BE
Marugan, JJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (10) : 2679 - 2684
[48] RES-1149-1 and-2, novel non-peptidic endothelin type B receptor antagonists produced by Aspergillus sp. .3. Biochemical properties of RES-1149-1,-2 and structure-activity relationships
Ogawa, T
Uosaki, Y
Tanaka, T
Tsukuda, E
Mihara, A
Matsuda, Y
JOURNAL OF ANTIBIOTICS, 1996, 49 (02): : 168 - 172
[49] Himbacine derived thrombin receptor (PAR-1) antagonists: Structure-activity relationship of the lactone ring
Xia, Yan
Chackalamannil, Samuel
Chan, Tze-Ming
Czarniecki, Michael
Doller, Dario
Eagen, Keith
Greenlee, William J.
Tsai, Hsingan
Wang, Yuguang
Ahn, Ho-Sam
Boykow, George C.
McPhail, Andrew T.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) : 4969 - 4972
[50] Structure-activity study of kinin B1 receptor antagonists
Regoli, D
Neugebauer, W
Gobeil, F
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R334 - R334

← 1 2 3 4 5 →